Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)
14.70
-0.16 (-1.08%)
Sep 23, 2026, 3:00 PM CST
SHA:603896 Market Cap
SHA:603896 has a market cap or net worth of 2.91 billion as of September 23, 2026. Its market cap has decreased by -30.17% in one year.
Market Cap
2.91B
Enterprise Value
2.53B
Revenue
616.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.70
ChartMarket Cap Chart
Since May 10, 2017, SHA:603896's market cap has increased from 2.32B to 2.91B, an increase of 25.42%. That is a compound annual growth rate of 2.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 2.91B | -24.15% |
| Dec 31, 2025 | 3.84B | -8.63% |
| Dec 31, 2024 | 4.20B | -34.21% |
| Dec 29, 2023 | 6.39B | -18.28% |
| Dec 30, 2022 | 7.82B | -11.47% |
| Dec 31, 2021 | 8.83B | 75.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 10, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Bioperfectus Technologies | 3.30B |
| Qingdao Vland Biotech INC. | 3.25B |
| Hinova Pharmaceuticals | 3.07B |
| Beijing Kawin Technology Share-Holding | 3.05B |
| Baolingbao Biology | 3.02B |
| Guanhao Biotech | 2.98B |
| Zhejiang East Asia Pharmaceutical | 2.78B |
| Guangdong VTR Bio-Tech | 2.76B |